Blueshift Asset Management, LLC Guardant Health, Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $92,829 - $249,144	-3,221 Reduced 34.26%	6,180 $249,000
Q1 2022 May 12, 2022	BUY	$48.25 - $100.49 $453,598 - $944,706	9,401 New	9,401 $623,000
Q4 2021 Feb 11, 2022	SELL	$88.71 - $120.43 $251,226 - $341,057	-2,832 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $2.06 Million - $2.75 Million	-20,828 Reduced 88.03%	2,832 $354,000
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $2.36 Million - $3.56 Million	21,474 Added 982.34%	23,660 $2.94 Million
Q1 2021 May 06, 2021	BUY	$127.04 - $179.1 $277,709 - $391,512	2,186 New	2,186 $334,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.